文献速递临床试验与 GCP

患者自控静脉镇痛联合氟比洛芬酯与地佐辛对肺叶切除术后镇痛效果的试验方案

Effect of patient-controlled intravenous analgesia combined with flurbiprofen axetil and dezocine on postoperative analgesia for lobectomy (EPIC-FAD): a trial protocol.
PubMed 文献 · Trials · 2021-03-01

该方案拟开展单中心、平行设计、双盲、优效性试验,比较氟比洛芬酯联合地佐辛与单药在肺叶切除术后镇痛中的效果,计划5组等比例分配。主要结局为术后24小时内自控静脉镇痛舒芬太尼总用量。试验尚未开始招募,预计2020年6月1日至2021年5月31日入组。

要点

  • 比较氟比洛芬酯联合地佐辛与两药单用对肺叶切除术后镇痛的效果。
  • 主要结局为术后24小时内自控静脉镇痛舒芬太尼总用量。
  • 试验尚未开始招募,计划2020年6月1日至2021年5月31日入组。

核心结论

  • 该试验尚未开始招募,若成功可能为肺叶切除术后镇痛组合的选择提供依据。

研究设计与样本

  • 单中心、平行设计、双盲、优效性试验,5组按1:1:1:1:1比例接受不同氟比洛芬与地佐辛组合。
  • 招募拟行肺叶切除术的患者,医生、患者和护士设盲,仅管理者非盲,分析采用意向性治疗。

关键数值与推荐

  • 主要结局为术后24小时内患者自控静脉镇痛中舒芬太尼总用量。
  • 次要结局包括术后6、12、24、48、72小时及术后1、3、6个月静息和咳嗽时疼痛数字评分。
  • 次要结局还包括试验药物不良事件、其他时间点舒芬太尼用量、镇痛费用、胸管拔除时间、住院时长、首次排气时间和血清细胞因子水平。
  • 统计比较采用单因素方差分析及Tukey事后检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal analgesic strategy for surgical pain after lobectomy remains undefined. To compare the combination of flurbiprofen axetil and dezocine with flurbiprofen axetil alone and dezocine alone, in post-lobectomy patients. METHODS: A single-center, parallel-design double-blind superiority trial, with 5 groups (1:1:1:1:1 ratio) with different combinations of flurbiprofen and dezocine. Patients scheduled for lobectomy will be recruited. The primary outcome is total sufentanil use in patient-controlled intravenous analgesia within the first 24 postoperative hours. Secondary outcomes include pain numeric rating scales at 6th, 12th, 24th, 48th, and 72th postoperative hours, and on the 1st, 3rd, and 6th postoperative months at rest and during coughing, adverse effects from experimental drug treatment, sufentanil use at other time points, analgesia cost, time to chest tube removal, length of hospital stay, time to pass first flatus, and serum level of cytokines. Doctors, patients, and nurses are blinded, and only the manager is unblinded. Analysis is intention-to-treat. Statistical analysis is pre-specified. Statistical comparison of the treatment groups includes one-way analysis of variance followed by Tukey's post hoc test. DISCUSSION: Trial did not begin to recruit. Participant recruitment start date is planned to be June 1, 2020. Approximate recruitment end date is May 31, 2021. If successful, the trial may shed light on the use of certain analgesic combinations in post-lobectomy pain control. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800018563 . Registered on September 25, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhou J, Pu Q, Lin L, et al. Effect of patient-controlled intravenous analgesia combined with flurbiprofen axetil and dezocine on postoperative analgesia for lobectomy (EPIC-FAD): a trial protocol. Trials. 2021. PMID: 33648558. doi:10.1186/s13063-021-05108-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。